Dr. Nina C. Botto, MD

Dr. Botto practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Botto's NPI, 1528299716, was assigned on August 5, 2009. Dr. Botto graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2009. Dr. Botto's Illinois license number on file is 125056327.

Dr. Botto's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Botto's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Botto is also affiliated with Evanston Hospital. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Botto to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Botto practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Botto's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Botto is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Botto's licenses on file in 3 states: Illinois, California and Massachusetts.

Dmand AI lists benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives, itchy rashes, joint cyst and psoriasis among the conditions Dr. Botto treats.

CMS data shows 1,261 Medicare services from Dr. Botto across 12 procedure codes in 2024, for 316 Medicare patients. Medicare paid $43,279 for them. Every service was in an office.

CMS counts 316 Medicare patients who saw Dr. Botto in 2024. The largest group is 65 to 74, with 146 patients. 66% of them have high cholesterol, and 54% have high blood pressure. 19% are also on Medicaid. Their average risk score is 0.93, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Botto's median patient age at 65, with 61% women.

In 2024, Dr. Botto wrote 868 Medicare Part D claims for 208 patients. 90% of them were for generic drugs. CMS names the drug for 753 of them, across 22 drugs with 11 or more claims each, at $271,689 in total drug cost. In 2023, CMS named 673 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Botto for performance year 2024, reported as part of a group. Dr. Botto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Botto as offering telehealth. CMS counts 331 procedures of removal of skin lesions by Dr. Botto, more than 83% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Botto, published from 2018 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Dermatitis, Allergic Contact, Patch Tests and Allergens. Dr. Botto has published most often in Dermatitis. Dr. Botto's most frequent co-authors are Jenny Eileen Murase, MD, Jodie S. Raffi and Carina Woodruff, MD.

Dmand AI lists 1 award for Dr. Botto, most recently CMS Stage 1 EHR in 2013.

Dr. Botto graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2009.

Dr. Botto is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.